Maximizing Endoscopic Video Interpretation for Inflammatory Bowel Disease

The Problem

There is an unmet need for precision disease assessment for IBD patients.

Colonoscopy

is the Best Biomarker for Assessment of IBD

Colonoscopy

is the Best Biomarker for Assessment of IBD

HOWEVER

Interpretation is Subjective

HOWEVER

Interpretation is Subjective

FURTHERMORE

Conventional Metrics Poorly Quantify Disease Distribution and Burden

FURTHERMORE

Conventional Metrics Poorly Quantify Disease Distribution and Burden

What We Do

Endoscopic Disease Assessment for IBD Patients
(using AI/ML)

Input Colonoscopy Video Frames

$

Signal Processing & AI/ML Models

$

Signal Processing & AI/ML Models

Disease Severity & Distribution

Our Impact / Value Proposition

Pharma / CROs

  • Increase visibility on therapeutic effect
  • Accelerate time to market

Payors

  • Reduce over / under prescription of drugs
  • Improve outcomes at lower cost

Providers

  • Demonstrate quality to payors
  • Clinical decision support
  • Expedite treatment authorization

Patients

  • Expand access to underserved populations
  • Improve outcomes

Product / Technology

Technology Developed by Gastroenterologists & Leading AI Experts

  • Licensed by University of Michigan to PathwaysGI

Developed & Validated Using

  • Real World Clinical Evidence
  • Randomized Clinical Trials
  • Global Endoscopic Video Data

Issued Patents

Peer-Reviewed Publications

National Presentations

Data Collection Sites

Maximizing the Value of IBD Endoscopic Video to Improve Outcomes and Lower Cost.